Accredited cases designed to support clinicians in applying data on HER2-targeted therapies to real-world NSCLC care. Test and refine your decision-making skills in an interactive scenario, including video commentary from Enriqueta Felip and David Planchard to apply evidence directly to patient care.
This video-based case study will explore the current landscape of HER2-targeted approaches in NSCLC including the role of ADCs and managing their associated treatment-related toxicities. Key clinical trial data on efficacy and safety of HER2-directed therapies, and HER2 mutations and overexpression will be covered, delivering practicial considerations for patient selection and sequencing with HER2 directed therapies.
The case study will take 15 minutes to complete.
This video-based case study will cover the prevalence and clinical impact of brain metastases in HER2-positive NSCLC, the limitations of traditional agents for CNS metastases, and guidance on managing patients with HER2-positive NSCLC and brain metastases, in the context of clinical data on HER2-targeted therapies with CNS activity.
The case study will take 15 minutes to complete.
